News
Preprint of Data from 1st 100 Participants in I...
New York, NY, and Tel Aviv, ISRAEL, Aug. 19, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire -- Tollo Health, a comprehensive medical diagnostics and related solutions company, today announced that its majority-owned...
Preprint of Data from 1st 100 Participants in I...
New York, NY, and Tel Aviv, ISRAEL, Aug. 19, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire -- Tollo Health, a comprehensive medical diagnostics and related solutions company, today announced that its majority-owned...
Tollo Health Completes Trial Design for Tollovi...
3-arm randomized, controlled study to evaluate 15-day and 30-day treatment regimens Finalizing contracts with two Long COVID clinics to recruit patients Institutional Review Board (IRB) protocol submission imminent New York,...
Tollo Health Completes Trial Design for Tollovi...
3-arm randomized, controlled study to evaluate 15-day and 30-day treatment regimens Finalizing contracts with two Long COVID clinics to recruit patients Institutional Review Board (IRB) protocol submission imminent New York,...
Tollo Health Announces First Long COVID Clinic ...
RTHM collaborating on Tollovid™ 3CL inhibitor immune support supplement case studies Tollovid biomarker data to support potential structure-function claims in Long COVID New York, NY, and Tel Aviv, ISRAEL, Aug....
Tollo Health Announces First Long COVID Clinic ...
RTHM collaborating on Tollovid™ 3CL inhibitor immune support supplement case studies Tollovid biomarker data to support potential structure-function claims in Long COVID New York, NY, and Tel Aviv, ISRAEL, Aug....
Tollo Health & The Alchemist’s Kitchen to Host ...
New York, NY, and Tel Aviv, ISRAEL, Sept. 13, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire -- Tollo Health, Ltd. (OTCQB: TOMDF), a comprehensive medical diagnostics and related solutions company, together with...
Tollo Health & The Alchemist’s Kitchen to Host ...
New York, NY, and Tel Aviv, ISRAEL, Sept. 13, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire -- Tollo Health, Ltd. (OTCQB: TOMDF), a comprehensive medical diagnostics and related solutions company, together with...
IRB-Waived Tollovid® Research Data in Acute & L...
Tollo Health, Ltd. (OTCQB: TOMDF), a comprehensive medical diagnostics and related solutions company, today announced preliminary data from its majority-owned joint venture 3CL Pharma Ltd.’s ongoing IRB-waived sponsored market research...
IRB-Waived Tollovid® Research Data in Acute & L...
Tollo Health, Ltd. (OTCQB: TOMDF), a comprehensive medical diagnostics and related solutions company, today announced preliminary data from its majority-owned joint venture 3CL Pharma Ltd.’s ongoing IRB-waived sponsored market research...
Protect Your House: Tollovid® is Informed Sport...
Tollo Health, Ltd. (OTCQB: TOMDF), a comprehensive medical diagnostics and related solutions company, today announced that its majority-owned subsidiary 3CL Pharma, Ltd. received LGC Group’s Informed Sport certification for Tollovid®,...
Protect Your House: Tollovid® is Informed Sport...
Tollo Health, Ltd. (OTCQB: TOMDF), a comprehensive medical diagnostics and related solutions company, today announced that its majority-owned subsidiary 3CL Pharma, Ltd. received LGC Group’s Informed Sport certification for Tollovid®,...